Haemonetics (NYSE:HAE) was given a new $81.00 price target on by analysts at Robert W. Baird.
Haemonetics (NYSE:HAE) was given a new $94.00 price target on by analysts at Barrington Research.
Haemonetics (NYSE:HAE) was given a new $80.00 price target on by analysts at Mizuho.
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Haemonetics (NYSE:HAE) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..